Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Rather than defaulting to the cheapest option, you can discuss whether your biomarker profile suggests better outcomes with semaglutide versus dual-action tirzepatide, or whether a microdose initiation ($129/mo) aligns with genetic sensitivity markers
Pregnancy and Breastfeeding GLP-1 medications are not recommended during pregnancy or breastfeeding
What to Expect During GLP-1 Therapy When starting GLP-1 therapy, patients typically undergo an initial consultation with their healthcare provider to determine if this treatment is appropriate
Bibcode:1956Natur.178...64H
We like the tolerability profile of that mechanism, but we are interested in building that out further. This is a clear signal to the market that their current $2.3B deal with Gubra (for an Amylin agonist) is just the foundation, and they are actively looking for additional assets, most likely a GLP-1, to create a CagriSema-like combination therapy
US$ 22.69
US$ 22.02
US$ 27.55
